RainDance, BGI, Paris Hospital Collaborate on HLA Sequencing for RA Study | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – RainDance Technologies, BGI, and the Hôpital Saint-Louis in Paris will collaborate on a study to sequence the human leukocyte antigen super-locus in order to gain insight into mutations associated with rheumatoid arthritis, RainDance said today.

The partners will use the RainDance Targeted Sequencing Platform and HLASeq Research Screening Panel to target the HLA super-locus in patient samples provided by Hôpital Saint-Louis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.